…ed analyses, enabling more confident peptide prioritization for cancer immunotherapy. By streamlining virtual screening, benchmarking, and peptide s…
All extracted treatments
Showing 1,141–1,200 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Articles mentioning treatments
7,227 articles · page 228 of 603…upporting metabolites such as butyrate as adjunct therapies for ICB immunotherapy.…
…was decreased in tumors responsive to immunmodulation including PD-1 blockade and anti-CD40 therapy. The TAN glycolysis score was associated …
…the field. Moreover, it would open the possibility of utilizing immunotherapies as a means of potential strategies for cancer prevention in ind…
…wide array of innovative cancer-related technologies, including immunotherapies. Through our funding model, the NCI SBIR program accelerates th…
…ng disease progression and advancing cancer treatments, such as immunotherapy. The cancer ecosystem is complex, composed of cells with dysreg…
… test the correlation between ICD-related genes and response to immunotherapy.References Ashbrook DG, Arends D, Prins P, Mulligan MK, Roy S, …
…une-based approaches focused on Immune Checkpoint Inhibitors or Adoptive Cell Therapies. This underscores the urgent need for a deeper, spatially resol…
…immune resistance in ovarian cancer and enhance the efficacy of immune checkpoint blockade, offering a promising combinatorial therapeutic approach.Refere…
… tumor-specific effector T cells, contributing to resistance to immunotherapy. 1 While the abundance of fibrotic stroma, suppressive myeloid …
…ll recruitment, and activation mechanisms. Clinically promising cancer immunotherapies harnessing cytokines and chemokines are expanding,2 yet the spa…
…l bases such as deoxyuridine (dU) is frequently observed due to antimetabolite therapy and dysregulated cytidine deaminase activity. However, the impa…